The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
Ioannis Varbobitis, George V. Papatheodoridis
Clin Mol Hepatol. 2016;22(3):319-326. Published online 2016 Sep 25 DOI: https://doi.org/10.3350/cmh.2016.0045
|
Citations to this article as recorded by
Evaluate the clinical efficacy of traditional Chinese Medicine as the neoadjuvant treatment in reducing the incidence of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis: A systematic review and meta-analysis
An Tu, Xiaoning Zhu, Paniz Zarghami Dastjerdi, Yue Yin, Mengyun Peng, Ding Zheng, Zhaoxuan Peng, Encheng Wang, Xiaodong Wang, Wang Jing
Heliyon.2024; 10(3): e24437. CrossRef Predictive Risk Factors and Scoring Systems Associated with the Development of Hepatocellular Carcinoma in Chronic Hepatitis B
Ploutarchos Pastras, Evaggelos Zazas, Maria Kalafateli, Ioanna Aggeletopoulou, Efthymios P. Tsounis, Stavros Kanaloupitis, Konstantinos Zisimopoulos, Eirini-Eleni-Konstantina Kottaridou, Aspasia Antonopoulou, Dimosthenis Drakopoulos, Georgia Diamantopoulo
Cancers.2024; 16(14): 2521. CrossRef Survey of hepatitis B virus infection status after 35 years of universal vaccination implementation in Taiwan
Kai‐Chi Chang, Mei‐Hwei Chang, Huey‐Ling Chen, Fang‐Wen Cheng, Jia‐Feng Wu, Wei‐Ju Su, Hong‐Yuan Hsu, Yen‐Hsuan Ni
Liver International.2024; 44(8): 2054. CrossRef Risk Factors and Comorbidities Associated With Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection
Helen Weidemann, Kristen Yeh, Krystal Hunter, Satyajeet Roy
Journal of Primary Care & Community Health.2024;[Epub] CrossRef Predictors of hepatic flares after nucleos(t)ide analogue cessation - Results of a global cohort study (RETRACT-B study)
Edo J. Dongelmans, Grishma Hirode, Bettina E. Hansen, Chien-Hung Chen, Tung-Hung Su, Wai-Kay Seto, Arno Furquim d'Almeida, Stijn van Hees, Margarita Papatheodoridi, Sabela Lens, Grace L.H. Wong, Sylvia M. Brakenhoff, Rong-Nan Chien, Jordan J. Feld, Henry
Journal of Hepatology.2024;[Epub] CrossRef Chronic hepatitis B and metabolic dysfunction-associated steatotic liver disease: Metabolic risk factors are key drivers of hepatocellular carcinoma
Gupse Adali, Huseyin Aykut, Nermin Mutlu Bilgic, Yusuf Yilmaz
Heliyon.2024; 10(18): e37990. CrossRef Long-term follow-up of treatment-naïve HBeAg-negative patients with chronic hepatitis B
Yusuf Emre Ozdemir, Meryem Sahin Ozdemir, Osman Faruk Bayramlar, Serkan Surme, Sibel Yildiz Kaya, Ridvan Karaali, Ilker Inanc Balkan, Bilgul Mete, Nese Saltoglu, Fehmi Tabak
Irish Journal of Medical Science (1971 -).2023; 192(2): 633. CrossRef A Comparative Trial of Improving Care for Underserved Asian Americans Infected with Hepatitis B Virus
Grace X. Ma, Lin Zhu, Yin Tan, Shumenghui Zhai, Xiaoli Ma, Olorunseun O. Ogunwobi, Wei Jenny Yang, Tsunyou Ting, Sara Kim, Min Qi Wang
Digestive Diseases and Sciences.2023; 68(6): 2333. CrossRef Racial and Ethnic Disparities in Characteristics and Care Patterns of Chronic Hepatitis B Patients in the United States
Joanne K. Liu, Leslie Y. Kam, Daniel Q. Huang, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
Clinical Gastroenterology and Hepatology.2023; 21(10): 2606. CrossRef Hepatitis B and C: neglected infectious diseases among Syrian refugees in Lebanon
Layal Al Mahmasani, Umayya Musharrafieh, Zeina Bayram, Abdul Rahman Bizri
Journal of Global Health Reports.2023;[Epub] CrossRef Risk prediction algorithms in guiding antiviral therapy initiation among patients with chronic hepatitis B in Thailand: an economic evaluation and budget impact analysis
Piyameth Dilokthornsakul, Ratree Sawangjit, Pisit Tangkijvanich, Maneerat Chayanupatkul, Pajaree Sriuttha, Unchalee Permsuwan
Expert Review of Pharmacoeconomics & Outcomes Research.2023; 23(8): 951. CrossRef Test All for Hepatitis B Virus
Katerina Roma, Zahra Dossaji, Lubaba Haque, Tooba Laeeq, Robert G. Gish, Carol Brosgart
Clinics in Liver Disease.2023; 27(4): 997. CrossRef Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral Therapy
Chih-Lang Lin, Szu-Yuan Wu, Ming-Wei Lai, Chao-Wei Hsu, Wan-Ming Chen, An-Tzu Jao, Cheng-Hung Chien, Ching-Chih Hu, Rong-Nan Chien, Chau-Ting Yeh
Cancers.2023; 15(13): 3343. CrossRef The Different Prognoses of Hepatocellular Carcinoma with Previous Tenofovir versus Entecavir Treatment for Chronic Hepatitis B Virus: Analysis Based on 15 Propensity Score-Matched Studies
Jiancun Hou, Zhe Qiang, Yang Li, Yamin Zhang
Digestive Diseases.2023; 41(3): 476. CrossRef Prognostic role of computed tomography analysis using deep learning algorithm in patients with chronic hepatitis B viral infection
Jeongin Yoo, Heejin Cho, Dong Ho Lee, Eun Ju Cho, Ijin Joo, Sun Kyung Jeon
Clinical and Molecular Hepatology.2023; 29(4): 1029. CrossRef Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
Soo Ryang Kim, Soo Ki Kim
Diagnostics.2023; 13(20): 3212. CrossRef State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection
Peter Schemmer, Patrizia Burra, Rey‐Heng Hu, Christian M. Hüber, Carmelo Loinaz, Keigo Machida, Arndt Vogel, Didier Samuel
Liver International.2022; 42(2): 288. CrossRef Therapeutic Advances in Viral Hepatitis A–E
Navroop Nagra, Richard A. Kozarek, Blaire E. Burman
Advances in Therapy.2022; 39(4): 1524. CrossRef Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases
Maria Stella Franzè, Teresa Pollicino, Giovanni Raimondo, Giovanni Squadrito
Liver International.2022; 42(5): 963. CrossRef Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992–2018
Christian S. Alvarez, Jessica L. Petrick, Dominick Parisi, Brian J. McMahon, Barry I. Graubard, Katherine A. McGlynn
Hepatology.2022; 76(3): 589. CrossRef Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani
World Journal of Gastroenterology.2022; 28(21): 2251. CrossRef Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus
Darren Jun Hao Tan, Cheng Han Ng, Phoebe Wen Lin Tay, Nicholas Syn, Mark D. Muthiah, Wen Hui Lim, Ansel Shao Pin Tang, Kai En Lim, Grace En Hui Lim, Nobuharu Tamaki, Beom Kyung Kim, Margaret Li Peng Teng, James Fung, Rohit Loomba, Mindie H. Nguyen, Daniel
JAMA Network Open.2022; 5(6): e2219407. CrossRef Changes in the Epidemiology of Hepatocellular Carcinoma in Asia
Yao Liu, Lianxin Liu
Cancers.2022; 14(18): 4473. CrossRef Improving Long-Term Adherence to Monitoring/Treatment in Underserved Asian Americans with Chronic Hepatitis B (CHB) through a Multicomponent Culturally Tailored Intervention: A Randomized Controlled Trial
Grace X. Ma, Lin Zhu, Wenyue Lu, Elizabeth Handorf, Yin Tan, Ming-Chin Yeh, Cicely Johnson, Guercie Guerrier, Minhhuyen T. Nguyen
Healthcare.2022; 10(10): 1944. CrossRef How to Effectively Monitor Aging Patients with Chronic Hepatitis B: A Review
Chan Keat Kang, Paul N Brennan, John F Dillon
Clinical Interventions in Aging.2022; Volume 17: 1811. CrossRef Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
Jung Woo Shin, Joonho Jeong, Seok Won Jung, Seung Bum Lee, Bo Ryung Park, Min-Ju Kim, Eun Ji Park, Neung Hwa Park
Digestive Diseases and Sciences.2021; 66(5): 1739. CrossRef Addition of liver stiffness enhances the predictive accuracy of the PAGE‐B model for hepatitis B‐related hepatocellular carcinoma
Hye Yeon Chon, Han Ah Lee, Sang Jun Suh, Jung Il Lee, Byung Seok Kim, In Hee Kim, Chang Hyeong Lee, Byoung Kuk Jang, Hyun Woong Lee, Jae Seok Hwang, Chang Hun Lee, Jin‐Woo Lee, Jung Hwan Yu, Yeon Seok Seo, Hyung Joon Yim, Seung Up Kim
Alimentary Pharmacology & Therapeutics.2021; 53(8): 919. CrossRef Tenofovir disoproxil fumarate on the risk of hepatocellular carcinoma in chronic hepatitis B patients with failure to preceding treatments: A nationwide cohort study
Jayoun Lee, Gi‐Ae Kim, Hyo Jeong Kim, Songhee Cho, Min Jung Ko, Young‐Suk Lim
Journal of Viral Hepatitis.2021; 28(8): 1150. CrossRef Treatment of Chronic Hepatitis B Virus with Oral Anti-Viral Therapy
Maria Buti, Mar Riveiro-Barciela, Rafael Esteban
Clinics in Liver Disease.2021; 25(4): 725. CrossRef Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
Joo Hyun Oh, Hye Won Lee, Dong Hyun Sinn, Jun Yong Park, Beom Kyung Kim, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik
Hepatology International.2021; 15(4): 892. CrossRef Viral Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Occurrence and Recurrence
Yuanyuan Liu, Vaishnavi Veeraraghavan, Monica Pinkerton, Jianjun Fu, Mark W. Douglas, Jacob George, Thomas Tu
Frontiers in Microbiology.2021;[Epub] CrossRef Maternal Hepatitis B or Hepatitis C Virus Carrier Status is Not a Risk Factor for Long-Term Oncologic Morbidity of the Offspring: A Population-Based Cohort Study
Naim Abu-Freha, Tamar Wainstock, Liat Poupko, Eyal Sheiner
Cancer Investigation.2021; 39(9): 690. CrossRef Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
Mi Young Jeon, Beom Kyung Kim, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Seung Up Kim
Clinical and Molecular Hepatology.2021; 27(2): 295. CrossRef Controversies in the Management of Hepatitis B
Stuart K. Roberts, Ammar Majeed, William Kemp
Clinics in Liver Disease.2021; 25(4): 785. CrossRef Hepatitis B Before and After Hepatocellular Carcinoma
Murat Harputluoglu, Brian I. Carr
Journal of Gastrointestinal Cancer.2021; 52(4): 1206. CrossRef SASLT practice guidelines for the management of Hepatitis B virus – An update
Faisal A. Abaalkhail, Waleed K. Al-Hamoudi, Abdullah Khathlan, Saad Alghamdi, Mohammed Alghamdi, Saleh A. Alqahtani, Faisal M. Sanai
Saudi Journal of Gastroenterology.2021; 27(3): 115. CrossRef Fibrosis-4, aspartate transaminase-to-platelet ratio index, and gamma-glutamyl transpeptidase-to-platelet ratio for risk assessment of hepatocellular carcinoma in chronic hepatitis B patients: comparison with liver biopsy
Mi Na Kim, Ju Ho Lee, Young Eun Chon, Yeonjung Ha, Seong Gyu Hwang
European Journal of Gastroenterology & Hepatology.2020; 32(3): 433. CrossRef BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR DIAGNOSIS AND TREATMENT OF HEPATOCELLULAR CARCINOMA
Aline Lopes CHAGAS, Angelo Alves de MATTOS, Flair José CARRILHO, Paulo Lisboa BITTENCOURT, Denise Cerqueira Paranaguá VEZOZZO, Natally HORVAT, Manoel de Souza ROCHA, Venâncio Avancini Ferreira ALVES, Gabriela Perdomo CORAL, Mario Reis ALVARES-DA-SILVA, Fa
Arquivos de Gastroenterologia.2020; 57(suppl 1): 1. CrossRef Entecavir and tenofovir on renal function in patients with hepatitis B virus‐related hepatocellular carcinoma
Mi Young Jeon, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn, Seung Up Kim
Journal of Viral Hepatitis.2020; 27(9): 932. CrossRef Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels
Lingmei Wang, Jiao Li, Kai Yang, Hao Zhang, Qin Wang, Xiongwen Lv, Shihe Guan
Medicine.2020; 99(23): e20548. CrossRef Carcinoma hepatocelular
L. Márquez Pérez, S. Alonso López, J.L. Herrera Fajes, L. Carrión Martín
Medicine - Programa de Formación Médica Continuada Acreditado.2020; 13(12): 653. CrossRef Documento de consenso de la Asociación Española para el Estudio del Hígado sobre el tratamiento de la infección por el virus de la hepatitis B (2020)
Manuel Rodríguez, María Buti, Rafael Esteban, Sabela Lens, Martín Prieto, Emilio Suárez, Javier García-Samaniego
Gastroenterología y Hepatología.2020; 43(9): 559. CrossRef Entecavir Reduced Serum Hepatitis B Core-Related Antigen in Chronic Hepatitis B Patients with Hepatocellular Carcinoma
Lung-Yi Mak, Kwan-Lung Ko, Wai-Pan To, Danny Ka-Ho Wong, Wai-Kay Seto, James Fung, Man-Fung Yuen
Gut and Liver.2020; 14(5): 665. CrossRef Saudi Association for the Study of Liver diseases and Transplantation practice guidelines on the diagnosis and management of hepatocellular carcinoma
SalehA Alqahtani, FaisalM Sanai, Ashwaq Alolayan, Faisal Abaalkhail, Hamad Alsuhaibani, Mazen Hassanain, Waleed Alhazzani, Abdullah Alsuhaibani, Abdullah Algarni, Alejandro Forner, RichardS Finn, WaleedK Al-hamoudi
Saudi Journal of Gastroenterology.2020; 26(7): 1. CrossRef Comparison of the on‐treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis
Ingyoon Ha, Jung Wha Chung, Eun Sun Jang, Sook‐Hyang Jeong, Jin‐Wook Kim
Journal of Gastroenterology and Hepatology.2020; 35(10): 1774. CrossRef Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
Simmone D'souza, Keith CK Lau, Carla S Coffin, Trushar R Patel
World Journal of Gastroenterology.2020; 26(38): 5759. CrossRef Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020)
Manuel Rodríguez, María Buti, Rafael Esteban, Sabela Lens, Martín Prieto, Emilio Suárez, Javier García-Samaniego
Gastroenterología y Hepatología (English Edition).2020; 43(9): 559. CrossRef Serum Mac‐2‐binding protein glycosylation isomer and risk of hepatocellular carcinoma in entecavir‐treated chronic hepatitis B patients
Lung‐Yi Mak, Michael Ko, Elvis To, Danny Ka‐Ho Wong, Justin Hei‐Chun Ma, Teresa Lok‐Yee Hui, Wai‐Kay Seto, James Fung, Ching‐Lung Lai, Man‐Fung Yuen
Journal of Gastroenterology and Hepatology.2019; 34(10): 1817. CrossRef Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B
Jonggi Choi, Hyo Jeong Kim, Jayoun Lee, Songhee Cho, Min Jung Ko, Young-Suk Lim
JAMA Oncology.2019; 5(1): 30. CrossRef Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients
Lung-Yi Mak, Wai-Pan To, Danny Ka-Ho Wong, James Fung, Fen Liu, Wai-Kay Seto, Ching-Lung Lai, Man-Fung Yuen
World Journal of Gastroenterology.2019; 25(11): 1398. CrossRef Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013
Meredith S. Shiels, Eric A. Engels, Elizabeth L. Yanik, Katherine A. McGlynn, Ruth M. Pfeiffer, Thomas R. O’Brien
Cancer.2019; 125(15): 2621. CrossRef Infection par le virus de l’hépatite B : histoire naturelle, manifestations cliniques et principes thérapeutiques
O. Paccoud, L. Surgers, K. Lacombe
La Revue de Médecine Interne.2019; 40(9): 590. CrossRef Updates on Chronic HBV: Current Challenges and Future Goals
Hannah M. Lee, Bubu A. Banini
Current Treatment Options in Gastroenterology.2019; 17(2): 271. CrossRef High risk of clinical events in untreated HBeAg‐negative chronic hepatitis B patients with high viral load and no significant ALT elevation
Gwang Hyeon Choi, Gi‐Ae Kim, Jonggi Choi, Seungbong Han, Young‐Suk Lim
Alimentary Pharmacology & Therapeutics.2019; 50(2): 215. CrossRef Serum Mac-2-Binding Protein Glycosylation Isomer at Virological Remission Predicts Hepatocellular Carcinoma and Death in Chronic Hepatitis B-Related Cirrhosis
Tung-Hung Su, Cheng-Yuan Peng, Tai-Chung Tseng, Hung-Chih Yang, Chun-Jen Liu, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen, Jia-Horng Kao
The Journal of Infectious Diseases.2019;[Epub] CrossRef Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis B
Shan Shan, Hong You, Junqi Niu, Jia Shang, Wen Xie, Yuexin Zhang, Xun Li, Hong Ren, Hong Tang, Huiguo Ding, Xihong Wang, Yuemin Nan, Xiaoguang Dou, Tao Han, Lingyi Zhang, Xiaoqing Liu, Cunliang Deng, Jilin Cheng, Xiaozhong Wang, Qing Xie, Shumei Lin, Yan
Journal of Clinical and Translational Hepatology.2019; X(X): 1. CrossRef Aspartate transaminase to platelet ratio index and gamma‐glutamyl transpeptidase‐to‐platelet ratio outweigh fibrosis index based on four factors and red cell distribution width‐platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepati
Xiaojuan Wu, Bei Cai, Zhenzhen Su, Yamei Li, Jin Xu, Rong Deng, Lanlan Wang
Journal of Clinical Laboratory Analysis.2018;[Epub] CrossRef Practical guidelines for performing laparoscopic liver resection based on the second international laparoscopic liver consensus conference
Jai Young Cho, Ho-Seong Han, Go Wakabayashi, Olivier Soubrane, David Geller, Nicholas O'Rourke, Joseph Buell, Daniel Cherqui
Surgical Oncology.2018; 27(1): A5. CrossRef Clinical states of cirrhosis and competing risks
Gennaro D'Amico, Alberto Morabito, Mario D'Amico, Linda Pasta, Giuseppe Malizia, Paola Rebora, Maria Grazia Valsecchi
Journal of Hepatology.2018; 68(3): 563. CrossRef Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
Ja Yoon Heo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Hyon-Suk Kim, Young Nyun Park, Kwang-Hyub Han, Kijun Song, Seung Up Kim
Gut and Liver.2018; 12(2): 190. CrossRef High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B
Gi-Ae Kim, Young-Suk Lim, Seungbong Han, Jonggi Choi, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Yung Sang Lee
Gut.2018; 67(5): 945. CrossRef EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle, Alejandro Forner, Josep M. Llovet, Vincenzo Mazzaferro, Fabio Piscaglia, Jean-Luc Raoul, Peter Schirmacher, Valérie Vilgrain
Journal of Hepatology.2018; 69(1): 182. CrossRef Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
Elia Moreno-Cubero, Robert T Sánchez del Arco, Julia Peña-Asensio, Eduardo Sanz de Villalobos, Joaquín Míquel, Juan Ramón Larrubia
World Journal of Gastroenterology.2018; 24(17): 1825. CrossRef Medication Nonadherence Increases Hepatocellular Carcinoma, Cirrhotic Complications, and Mortality in Chronic Hepatitis B Patients Treated With Entecavir
Jung Woo Shin, Seok Won Jung, Seung Bum Lee, Byung Uk Lee, Bo Ryung Park, Eun Ji Park, Neung Hwa Park
American Journal of Gastroenterology.2018; 113(7): 998. CrossRef Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma
Lung-Yi Mak, Vania Cruz-Ramón, Paulina Chinchilla-López, Harrys A. Torres, Noelle K. LoConte, John P. Rice, Lewis E. Foxhall, Erich M. Sturgis, Janette K. Merrill, Howard H. Bailey, Nahum Méndez-Sánchez, Man-Fung Yuen, Jessica P. Hwang
American Society of Clinical Oncology Educational Book.2018; (38): 262. CrossRef Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment
Nam Hee Kim, Yong Kyun Cho, Byung Ik Kim, Hong Joo Kim
Digestive Diseases and Sciences.2018; 63(10): 2792. CrossRef A combination of the on‐treatment FIB‐4 and alpha‐foetoprotein predicts clinical outcomes in cirrhotic patients receiving entecavir
Hung‐Hsien Chiang, Chuan‐Mo Lee, Tsung‐Hui Hu, Chao‐Hung Hung, Jing‐Houng Wang, Sheng‐Nan Lu, Hsueh‐Chou Lai, Wen‐Pang Su, Chia‐Hsin Lin, Cheng‐Yuan Peng, Chien‐Hung Chen
Liver International.2018; 38(11): 1997. CrossRef Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
Byeong G. Song, Dong H. Sinn, Sangah Chi, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik
European Journal of Gastroenterology & Hepatology.2018; 30(12): 1447. CrossRef Is Combination Antiviral Therapy Mandatory for Maintenance Therapy in Fully Suppressed Multidrug-Resistant Hepatitis B Patients?
Sung Won Chung, Young Chang, Hyo Young Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim
Gastroenterology Research and Practice.2018; 2018: 1. CrossRef EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
Pietro Lampertico, Kosh Agarwal, Thomas Berg, Maria Buti, Harry L.A. Janssen, George Papatheodoridis, Fabien Zoulim, Frank Tacke
Journal of Hepatology.2017; 67(2): 370. CrossRef Detection of HBV Covalently Closed Circular DNA
Xiaoling Li, Jinghua Zhao, Quan Yuan, Ningshao Xia
Viruses.2017; 9(6): 139. CrossRef Gamma‐glutamyl transpeptidase‐to‐platelet ratio is an independent predictor of hepatitis B virus‐related liver cancer
Yong Eun Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Sojung Han, Mi Young Jeon, Ja Yoon Heo, Kijun Song, Seung Up Kim
Journal of Gastroenterology and Hepatology.2017; 32(6): 1221. CrossRef Effect of modified Xiaochaihu decoction-containing serum on HepG2.2.15 cells via the JAK2/STAT3 signaling pathway
Shaofang Chen, Zhanglin Wang, Shichuan Wan, Hai Huang, Huiqing Liang
Molecular Medicine Reports.2017; 16(5): 7416. CrossRef
|